Schedule 13G ownership disclosure

Ironwood Pharmaceuticals Inc

Security class unavailable · CUSIP: 46333X108

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
21,777,701
Percent of class
13.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-20-000252
Form type
SC 13G/A
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
Jan 28, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub